Plasmaexchange in Myasthenia Gravis

Abstract

Get full access to this article

View all access options for this article.

References

Lindstrom

, Shelton

, Fujii

. Myasthenia gravis. Adv Immunol 1988; 42: 233–84.

Oosterhuis

HJGH

. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiat 1989; 52: 1121–7.

De Baets

M.H.

, Kuks

J.B.M.

. Immunopathology of myasthenia gravis. In: De Baets

M.H.

, Oosterhuis

HJGH

eds. myasthenia gravis. Boca Raton: CRC Press 1993; 147–202.

Bergström

, Franksson

, Matell

, Von Reis

. The effect of thoracic duct lymph drainage in myasthenia gravis. Europ Neurol 1973; 9: 157–67.

Pinching

A.J.

, Peters

D.K.

, Newsom-Davis

. Remission of myasthenia gravis following plasma-exchange. Lancet 1976; ii: 1373–6.

Dau

P.C.

(ed.) Plasmapheresis and the immunobiology of myasthenia gravis. Boston Massachusetts: Houghton Mifflin Publ 1979.

Riley

T.L.

, Monaghan

W.P.

. Antireceptor-antibody decline without improvement after plasmapheresis in myasthenia gravis. Ann Intern Med 1980; 92: 173.

Miller

R.G.

, Milner-Brown

H.S.

, Dau

P.C.

. Antibody-negative acquired myasthenia gravis. Successful therapy with plasma exchange. Muscle & Nerve 1981; 4: 255.

Seybold

M.E.

. Plasmapheresis in myasthenia gravis. Ann NY Acad Sci 1987; 505: 584–7.

10.

Dau

P.C.

, Lindstrom

J.M.

, Cassel

C.K.

, Denys

E.H.

, Shev

E.E.

, Spi-tler

L.E.

. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977; 297: 1134–40.

11.

Kornfeld

, Ambinder

E.P.

, Mittag

. Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol 1981; 38: 478–81.

12.

Durelli

, Cocito

, Bergamini

. Rapid improvement of myasthenia gravis after plasma exchange ? Ann Neurol 1983; 13: 220–1.

13.

Keesey

, Buffkin

, Kebo

, Ho

, Herrmann

. Plasma exchange alone as therapy for myasthenia gravis. Ann NY Acad Sci 1981; 377: 729–43.

14.

Consensus Conference. The utility of therapeutic plasmapheresis for neurological disorders. JAMA 1986; 256: 1333–7.

15.

Seybold

M.E.

, Tsoukas

, Lindstrom

, Fong

, Vaughan

. Leukoplasmapheresis for myasthenia gravis. Acetylcholine receptor antibody production. Arch Neurol 1982; 39: 433–5.

16.

Thornton

C.A.

, Griggs

R.C.

. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994; 35: 260–8.

17.

Rodnitzky

R.L.

, Bosch

E.P.

. Chronic long-interval plasma exchange in myasthenia gravis. Ann Neurol 1984; 41: 715–7.

18.

Blom

R.J.

, Kuks

J.B.M.

, Westerterp-Maas

, Oosterhuis

HJGH

. Favourable results of plasma exchange in severe myasthenia gravis. Ned Tijdschr Geneeskd 1997; 141: 381–4.

19.

Dau

P.C.

. Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients. Ann NY Acad Sci 1981; 377: 700–8.

20.

Fornadi

, Horvath

, Szobor

. Myasthenia Gravis: Treatment with plasma exchange. Experiences over 10 years. Acta Med Hung 1991; 48: 137–44.

21.

Sato

, Nishimiya

, Arai

. Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunosorbent. In: Oda

ed. Therapeutic Plasmapheresis. Vol III. Stuttgart: SchattauerVerlag. 1983; 565–8.

22.

Szpirt

, Somnier

, Gammeltoft

. Removal of anti acetylcholine receptor antibodies by immunoadsorption to protein A column. Artif Organs 1985; 10: 71–82.

23.

Grob

, Simpson

, Mitsumoto

. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurol 1995; 45: 338–44.

24.

Shibuya

, Sato

, Osarne

, Takegami

, Doi

, Kawanami

. Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiat 1994; 57: 578–81.

25.

Gajdos

, Outin

H.D.

, Elkharrat

. High dose interve-nous gamma globulin for myasthenia gravis. Lancet 1984; i: 406–7.

26.

Edan

, Landgraf

. Experience with intravenous immunoglobulin in myasthenia gravis: a review. J Neurol Neurosurg Psychiat 1994; 57: 55–6.

27.

Gelfand

E.W.

. Intervention in autoimmune disorders: creation of a niche for intravenous gamma-globulin therapy. Clin Immunol Immunopathol 1989; 53(suppl): S1–6.

28.

Gajdos

, Chevret

, Clair

, Tranchant

, Chastang

. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997; 41: 789–96.

29.

Dalakas

M.C.

. High-dose intravenous immunoglobulin and serum visocosity: risk of precipitating thromboembolic events. Neurology 1994; 44: 223–6.

30.

Strieker

R.B.

, Kwiatkowska

B.J.

, Habis

J.A.

, Kiprov

D.D.

. Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin. Arch Neurol 1993; 50: 837–40.

31.

Bussel

J.B.

, Saal

, Gordon

. Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfusion 1988; 28: 38–41.

32.

Oosterhuis

HJGH

. Myasthenia gravis: Edinburgh. Churchill Livingstone 1984; 46.